Validation of σ2R/TMEM97 as a neuropathic pain target: Specificity, human expression and mechanism of action

The Sigma 2 receptor (σ2R) was described pharmacologically more than three decades ago, but its molecular identity remained obscure until recently when it was identified as transmembrane protein 97 (TMEM97). We and others have shown that σ2R/TMEM97 ligands produce analgesia in mouse neuropathic pain models with a time course wherein analgesic onset is 24 hours following dosing. We sought to understand this unique anti-neuropathic pain effect by addressing two key questions: do these σ2R/TMEM97 compounds act selectively via the receptor, and what is their downstream mechanism on nociceptive neurons. Using male and female conventional knockout (KO) mice for Tmem97, we find that a novel σ2R/TMEM97 binding compound, FEM-1689, requires the presence of the gene to produce analgesia in the spared nerve injury model in mice. Using primary mouse dorsal root ganglion (DRG) neurons, we demonstrate that FEM-1689 inhibits the integrated stress response and promotes neurite outgrowth via a σ2R/TMEM97-specific action. We extend the clinical translational value of these findings by showing that FEM-1689 reduces ISR and p-eIF2α levels in human sensory neurons and that it alleviates the pathogenic engagement of ISR by methylglyoxal. We also demonstrate that σ2R/TMEM97 is expressed in human nociceptors and satellite glial cells. These results validate σ2R/TMEM97 as a promising target for further development for the treatment of neuropathic pain. Significance Statement Neuropathic pain is a major medical problem that is poorly treated with existing therapeutics. Our findings demonstrate that σ2R/TMEM97 targeting with modulators creates analgesia in a mouse model via a specific action on the receptor. We also identify a potential mechanism of action, ISR inhibition, that links the receptor to cellular signaling events that have preclinical and clinical validation for pain relief. Our work suggests that σ2R/TMEM97 can be selectively engaged by specific small molecules to produce ISR inhibition in a subset of cells that are critical for neuropathic pain. σ2R/TMEM97-targeted therapeutics thus have the potential to offer effective pain relief without the side effects associated with currently available neuropathic pain medicines.

[1]  V. Porciatti,et al.  σ2R/TMEM97 in retinal ganglion cell degeneration , 2022, Scientific Reports.

[2]  C. Ross,et al.  Neuroprotective Effects of σ2R/TMEM97 Receptor Modulators in the Neuronal Model of Huntington's Disease. , 2022, ACS chemical neuroscience.

[3]  S. Martin.  Bridging Known and Unknown Unknowns: From Natural Products and Their Mimics to Unmet Needs in Neuroscience. , 2022, Accounts of chemical research.

[4]  Yun-Jing Huang,et al.  A011, a novel small-molecule ligand of σ2 receptor, potently suppresses breast cancer progression via endoplasmic reticulum stress and autophagy. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  P. Dougherty,et al.  Spatial transcriptomics of dorsal root ganglia identifies molecular signatures of human nociceptors , 2022, Science Translational Medicine.

[6]  Yurii S. Moroz,et al.  Structures of the σ2 receptor enable docking for bioactive ligand discovery , 2021, Nature.

[7]  M. Synofzik,et al.  Intracellular Lipid Accumulation and Mitochondrial Dysfunction Accompanies Endoplasmic Reticulum Stress Caused by Loss of the Co-chaperone DNAJC3 , 2021, Frontiers in Cell and Developmental Biology.

[8]  Jeffrey J. Jones,et al.  A proteome-wide map of 20(S)-hydroxycholesterol interactors in cell membranes , 2021, Nature Chemical Biology.

[9]  G. Salido,et al.  TMEM97 facilitates the activation of SOCE by downregulating the association of cholesterol to Orai1 in MDA-MB-231 cells. , 2021, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[10]  G. Rishton,et al.  Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein , 2020, Journal of neuroscience research.

[11]  P. Cottone,et al.  The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice , 2020, Neuropharmacology.

[12]  Stephanie I. Shiers,et al.  Pharmacological Manipulation of Translation as a Therapeutic Target for Chronic Pain , 2020, Pharmacological Reviews.

[13]  Stephanie I. Shiers,et al.  Convergence of peptidergic and non-peptidergic protein markers in the human dorsal root ganglion and spinal dorsal horn , 2020, bioRxiv.

[14]  T. Simmen,et al.  Endoplasmic reticulum–mitochondria interplay in chronic pain: The calcium connection , 2020, Molecular pain.

[15]  T. Simmen,et al.  Endoplasmic reticulum stress in the dorsal root ganglia regulates large‐conductance potassium channels and contributes to pain in a model of multiple sclerosis , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[17]  J. Trojanowski,et al.  The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein Aggregates , 2020, Molecular Neurobiology.

[18]  G. Ebenezer,et al.  Intraepidermal Nerve Fiber Analysis in Human Patients and Animal Models of Peripheral Neuropathy: A Comparative Review , 2020, Toxicologic pathology.

[19]  P. Walter,et al.  Structural insights into ISRIB, a memory‐enhancing inhibitor of the integrated stress response , 2020, The FEBS journal.

[20]  M. B. Lourenço,et al.  Suppression of MEHMO Syndrome Mutation in eIF2 by Small Molecule ISRIB. , 2019, Molecular cell.

[21]  M. Burton,et al.  Indirect AMP-Activated Protein Kinase Activators Prevent Incision-Induced Hyperalgesia and Block Hyperalgesic Priming, Whereas Positive Allosteric Modulators Block Only Priming in Mice , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[22]  M. Hayden,et al.  Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptor , 2019, Neurobiology of Disease.

[23]  A. Kavelaars,et al.  Alleviation of paclitaxel-induced mechanical hypersensitivity and hyperalgesic priming with AMPK activators in male and female mice , 2019, Neurobiology of pain.

[24]  P. Shah,et al.  Intercepting the Lipid-Induced Integrated Stress Response Reduces Atherosclerosis , 2019, Journal of the American College of Cardiology.

[25]  Peter A. Smith,et al.  Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis , 2019, eNeuro.

[26]  L. Schneider,et al.  A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease , 2019, Alzheimer's & dementia.

[27]  N. Sonenberg,et al.  Nociceptor Translational Profiling Reveals the Ragulator-Rag GTPase Complex as a Critical Generator of Neuropathic Pain , 2018, The Journal of Neuroscience.

[28]  M. Shin,et al.  Neuroprotective Efficacy of a Sigma 2 Receptor/TMEM97 Modulator (DKR-1677) after Traumatic Brain Injury. , 2018, ACS chemical neuroscience.

[29]  R. Mach,et al.  Sigma-2 Receptor/TMEM97 and PGRMC-1 Increase the Rate of Internalization of LDL by LDL Receptor through the Formation of a Ternary Complex , 2018, Scientific Reports.

[30]  James M. Dahlhamer,et al.  Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016 , 2018, MMWR. Morbidity and mortality weekly report.

[31]  V. Granados-Soto,et al.  Activation of the integrated stress response in nociceptors drives methylglyoxal-induced pain , 2018, Pain.

[32]  Wensheng Lin,et al.  Activating transcription factor 6α deficiency exacerbates oligodendrocyte death and myelin damage in immune‐mediated demyelinating diseases , 2018, Glia.

[33]  J. Bruna,et al.  Sigma-1 receptor: a new player in neuroprotection against chemotherapy-induced peripheral neuropathy , 2018, Neural regeneration research.

[34]  Michael D. Wood,et al.  Small molecule modulators of σ2R/Tmem97 reduce alcohol withdrawal-induced behaviors , 2018, Neuropsychopharmacology.

[35]  Sertan Kutal Gökçe,et al.  High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model. , 2018, ACS chemical neuroscience.

[36]  A. Bang,et al.  High-throughput screen for compounds that modulate neurite growth of human induced pluripotent stem cell-derived neurons , 2018, Disease Models & Mechanisms.

[37]  M. Burton,et al.  Pharmacological activation of AMPK inhibits incision-evoked mechanical hypersensitivity and the development of hyperalgesic priming in mice , 2017, Neuroscience.

[38]  P. Ray,et al.  Sigma 2 Receptor/Tmem97 Agonists Produce Long Lasting Antineuropathic Pain Effects in Mice. , 2017, ACS chemical neuroscience.

[39]  James J. Sahn,et al.  Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity. , 2017, ACS medicinal chemistry letters.

[40]  A. Crisp,et al.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease , 2017, Journal of neurochemistry.

[41]  Mila Ljujic,et al.  The integrated stress response , 2016, EMBO reports.

[42]  K. Dikranian,et al.  Surgical extraction of human dorsal root ganglia from organ donors and preparation of primary sensory neuron cultures , 2016, Nature Protocols.

[43]  D. Grimm,et al.  Reduction of TMEM97 increases NPC1 protein levels and restores cholesterol trafficking in Niemann-pick type C1 disease cells , 2016, Human molecular genetics.

[44]  Wensheng Lin,et al.  The unfolded protein response in multiple sclerosis , 2015, Front. Neurosci..

[45]  F. Haj,et al.  Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain , 2015, Proceedings of the National Academy of Sciences.

[46]  Dong Woon Kim,et al.  Endoplasmic reticulum stress impairment in the spinal dorsal horn of a neuropathic pain model , 2015, Scientific Reports.

[47]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[48]  S. Linnarsson,et al.  Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing , 2014, Nature Neuroscience.

[49]  Gary Look,et al.  Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity , 2014, PloS one.

[50]  Miles Miller,et al.  Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits , 2014, PloS one.

[51]  Arne V. Blackman,et al.  Neuronal morphometry directly from bitmap images , 2014, Nature Methods.

[52]  Zong-Wen Wu,et al.  Sigma‐2 Receptor Ligands and Their Perspectives in Cancer Diagnosis and Therapy , 2014, Medicinal research reviews.

[53]  Cyril Bories,et al.  A simplified up-down method (SUDO) for measuring mechanical nociception in rodents using von Frey filaments , 2014, Molecular pain.

[54]  I. Obrosova,et al.  Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral Neuropathy , 2013, Diabetes.

[55]  J. Nordenström.  The calcium connection , 2013 .

[56]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[57]  S. Martin,et al.  Expedient synthesis of norbenzomorphan library via multicomponent assembly process coupled with ring-closing reactions. , 2012, ACS combinatorial science.

[58]  D. Zamanillo,et al.  Pharmacological properties of S1RA, a new sigma‐1 receptor antagonist that inhibits neuropathic pain and activity‐induced spinal sensitization , 2012, British journal of pharmacology.

[59]  J. McClintick,et al.  The eIF2 kinase PERK and the integrated stress response facilitate activation of ATF6 during endoplasmic reticulum stress , 2011, Molecular biology of the cell.

[60]  N. Sonenberg,et al.  Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain , 2011, Molecular pain.

[61]  J. Vela,et al.  Sigma-1 receptors regulate activity-induced spinal sensitization and neuropathic pain after peripheral nerve injury , 2009, PAIN.

[62]  H. Erfle,et al.  Identification of cholesterol-regulating genes by targeted RNAi screening. , 2009, Cell metabolism.

[63]  N. Colabufo,et al.  F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells. , 2009, Cell calcium.

[64]  Anne Bertolotti,et al.  Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response , 2000, Nature Cell Biology.

[65]  W. Bowen,et al.  Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. , 2000, The Journal of pharmacology and experimental therapeutics.

[66]  E. Kempner,et al.  Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[68]  M. Burton,et al.  The antidiabetic drug metformin prevents and reverses neuropathic pain and spinal cord microglial activation in male but not female mice , 2019, Pharmacological research.

[69]  L. Romero,et al.  Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects. , 2016, Advances in pharmacology.

[70]  J. Loren,et al.  eIF2.ALPHA. phosphorylation controls thermal nociception , 2016 .

[71]  Karl H. Wolf,et al.  Comparative review , 2011, J. Documentation.